Proprio
United States
- Seattle, WA
- 28/07/2023
- Series B
- $43,000,000
Proprio is a medical technology company based in Seattle, Washington. We create the new way of seeingâ„¢ in surgery through a proprietary platform of artificial intelligence, computer vision, and augmented/virtual reality. Our goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology. We work closely with industry-leading medical and technical advisors and reputable research institutions specializing in neurosurgery, medical devices, AI, computer vision, and robotics to dimensionalize and digitize surgical vision in groundbreaking, real-time applications. A quickly-growing, award-winning company, our team consists of creative, diverse, multi-disciplinary thinkers and innovators who value designing technology for positive and unprecedented social and industry impact.
- Industry Medical Equipment Manufacturing
- Website https://www.propriovision.com/
- LinkedIn https://www.linkedin.com/company/proprio-vision/
Related People
Gabriel JonesCo Founder
United States -
ND
Entrepreneur and business leader in technology and medicine with 20+ year track record in strategy, business development, marketing and product development. ~$40M raised from Seed to Commercialization stages.
There is nothing more motivating to me than a product that excites and empowers the user. When technology is nearly invisible, when it just works, that's when we know we've got it right.
Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Origin Lab | $8,000,000 | (May 14, 2026)
CREATE Medicines | $122,000,000 | (May 14, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)
Saile Medical (Saile App) | $2,200,000 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)